Company Profiles

driven by the PitchBook Platform

HemoShear Therapeutics

HemoShear Therapeutics
2008 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Later Stage VC LATEST DEAL TYPE (In Progress)
$800k LATEST DEAL AMOUNT
$21.7M TOTAL AMOUNT RAISED
Description

Developer of technologies to replicate the biology of organ systems and diseases designed to discover and develop drugs that profoundly improve the health of patients. The company's drug discovery platform focuses on discovering novel biological targets and developing drugs to treat rare metabolic disorders, providing medical institutes with insights into complex pathophysiological pathways.

Formerly Known As
HemoShear
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
501 Locust Avenue
Suite 301
Charlottesville, VA 22902
United States
+1 (434) 872-0196
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore HemoShear Therapeutics’s full profile, request a free trial.

HemoShear Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 15-May-2017 $800k $21.7M In Progress Generating Revenue
12. Later Stage VC 30-Mar-2017 00.000 000.00 Completed Generating Revenue
11. Grant 18-Jun-2014 000.00 Completed Generating Revenue
10. Later Stage VC (Series C1) 07-May-2014 00.00 000.00 Completed Generating Revenue
9. Grant 01-Jan-2013 00.000 00.00 Completed Startup
8. Early Stage VC 24-Oct-2012 000 00.00 Completed Startup
7. Grant 07-Apr-2011 00.000 Completed Startup
6. Grant 01-Jan-2011 00.000 00.000 Completed Startup
5. Angel (individual) 10-Sep-2010 00000 00.000 Completed Startup
4. Grant 14-Apr-2010 00.000 Completed Startup
3. Grant 01-Jan-2010 00000 00.000 Completed Startup
2. Angel (individual) 01-Aug-2009 $5M $5.28M Completed Startup
1. Angel (individual) 08-Aug-2008 $275k $275k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

HemoShear Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ed Williams Angel (individual) Minority 000 0000 000000 0
Main Line Equity Partners PE/Buyout Minority 000 0000 000000 0
United States Small Business Administration Limited Partner 000 0000 000000 0
Virginia Capital Partners Venture Capital Minority 000 0000 000000 0

HemoShear Therapeutics Executive Team (8)

Name Title Board
Seat
Contact
Info
James Powers Chief Executive Officer & Chairman
Aric Holsinger Chief Financial Officer
Richard White Jr. Vice President, Finance & Controller
David Manka Director of Translational Science
Michael Simmers Director, Research & Innovation
You’re viewing 5 of 8 executives. Get the full list »

HemoShear Therapeutics Board Members (11)

Name Representing Role Since Contact
Info
James Powers HemoShear Therapeutics Chief Executive Officer & Chairman 000 0000
John Brooks III Self Board Member 000 0000
Mehmood Khan MD Self Board Member 000 0000
Reginald Woods Self Board Member 000 0000
Robert Gould Ph.D HemoShear Therapeutics Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 11 board members. Get the full list »